Bacitracin | hsa00310 | Lysine degradation | 2.88E-02 | 2 | Q9NVH6, O15047 | TMLHE, SETD1A | More | |
Bacitracin | hsa00500 | Starch and sucrose metabolism | 2.88E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | |
Bacitracin | hsa00730 | Thiamine metabolism | 4.56E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Bacitracin | hsa01100 | Metabolic pathways | 4.89E-03 | 17 | Q96DU7, Q08828, Q02153, O43286, O43451, P05186, P24666, Q86XP1, O60701, P33121, Q9UHK6, Q86VZ5, P57054, P06737, P05166, O15047, Q9NVH6 | ITPKC, ADCY1, GUCY1B3, B4GALT5, MGAM, ALPL, ACP1, DGKH, UGDH, ACSL1, AMACR, SGMS1, PIGP, PYGL, PCCB, SETD1A, TMLHE | More | |
Bacitracin | hsa04012 | ErbB signaling pathway | 6.79E-03 | 4 | P21860, P49841, Q13557, O14944 | ERBB3, GSK3B, CAMK2D, EREG | More | |
Bacitracin | hsa04020 | Calcium signaling pathway | 1.71E-03 | 6 | Q96DU7, Q08828, Q13557, P21860, Q93086, P63092 | ITPKC, ADCY1, CAMK2D, ERBB3, P2RX5, GNAS | More | |
Bacitracin | hsa04072 | Phospholipase D signaling pathway | 8.42E-03 | 5 | Q9UQC2, P25025, P63092, Q08828, Q86XP1 | GAB2, CXCR2, GNAS, ADCY1, DGKH | More | |
Bacitracin | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.86E-02 | 4 | P63092, Q08828, Q13557, Q16539 | GNAS, ADCY1, CAMK2D, MAPK14 | More | |
Bacitracin | hsa04540 | Gap junction | 2.74E-02 | 3 | Q08828, Q02153, P63092 | ADCY1, GUCY1B3, GNAS | More | |
Bacitracin | hsa04611 | Platelet activation | 1.75E-02 | 4 | Q02153, Q16539, Q08828, P63092 | GUCY1B3, MAPK14, ADCY1, GNAS | More | |
Bacitracin | hsa04713 | Circadian entrainment | 6.79E-03 | 4 | Q13557, Q02153, Q08828, P63092 | CAMK2D, GUCY1B3, ADCY1, GNAS | More | |
Bacitracin | hsa04714 | Thermogenesis | 1.53E-02 | 5 | Q16539, P63092, Q08828, P51531, P33121 | MAPK14, GNAS, ADCY1, SMARCA2, ACSL1 | More | |
Bacitracin | hsa04728 | Dopaminergic synapse | 3.19E-02 | 4 | P63092, P49841, Q16539, Q13557 | GNAS, GSK3B, MAPK14, CAMK2D | More | |
Bacitracin | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.14E-03 | 4 | P63092, Q08828, Q13557, Q16539 | GNAS, ADCY1, CAMK2D, MAPK14 | More | |
Bacitracin | hsa04911 | Insulin secretion | 1.29E-02 | 3 | Q08828, P63092, Q13557 | ADCY1, GNAS, CAMK2D | More | |
Bacitracin | hsa04912 | GnRH signaling pathway | 3.64E-03 | 4 | Q08828, Q13557, Q16539, P63092 | ADCY1, CAMK2D, MAPK14, GNAS | More | |
Bacitracin | hsa04916 | Melanogenesis | 2.87E-03 | 4 | Q13557, P63092, Q08828, P49841 | CAMK2D, GNAS, ADCY1, GSK3B | More | |
Bacitracin | hsa04921 | Oxytocin signaling pathway | 1.75E-02 | 4 | Q08828, P63092, Q13557, Q02153 | ADCY1, GNAS, CAMK2D, GUCY1B3 | More | |
Bacitracin | hsa04924 | Renin secretion | 4.69E-02 | 2 | P63092, Q02153 | GNAS, GUCY1B3 | More | |
Bacitracin | hsa04925 | Aldosterone synthesis and secretion | 3.20E-02 | 3 | Q08828, P63092, Q13557 | ADCY1, GNAS, CAMK2D | More | |
Bacitracin | hsa04926 | Relaxin signaling pathway | 2.55E-02 | 4 | P63092, Q08828, P37173, Q16539 | GNAS, ADCY1, TGFBR2, MAPK14 | More | |
Bacitracin | hsa04934 | Cushing syndrome | 8.14E-03 | 4 | Q08828, P63092, P49841, Q13557 | ADCY1, GNAS, GSK3B, CAMK2D | More | |
Bacitracin | hsa04935 | Growth hormone synthesis, secretion and action | 1.53E-02 | 4 | Q08828, P63092, P49841, Q16539 | ADCY1, GNAS, GSK3B, MAPK14 | More | |
Bacitracin | hsa04970 | Salivary secretion | 1.60E-02 | 3 | P63092, Q08828, Q02153 | GNAS, ADCY1, GUCY1B3 | More | |
Bacitracin | hsa04971 | Gastric acid secretion | 2.32E-02 | 3 | Q08828, P63092, Q13557 | ADCY1, GNAS, CAMK2D | More | |
Bacitracin | hsa04976 | Bile secretion | 1.02E-02 | 3 | O43315, P63092, Q08828 | AQP9, GNAS, ADCY1 | More | |
Bacitracin | hsa05142 | Chagas disease | 1.13E-02 | 4 | Q16539, P37173, P63092, Q08828 | MAPK14, TGFBR2, GNAS, ADCY1 | More | |
Bacitracin | hsa05225 | Hepatocellular carcinoma | 3.91E-02 | 4 | P49841, Q92837, P37173, P51531 | GSK3B, FRAT1, TGFBR2, SMARCA2 | More | |
Bacitracin | hsa05414 | Dilated cardiomyopathy | 4.79E-02 | 3 | P26012, P63092, Q08828 | ITGB8, GNAS, ADCY1 | More | |